Funder: National Institutes of Health
Due Dates: January 5, 2026 (estimated, forecasted)
Funding Amounts: Not yet specified; large, multisite clinical trials supported; UG3/UH3 mechanism.
Summary: Supports planning and implementation of large-scale clinical trials evaluating interventions to reduce opioid use, improve function, and relieve pain.
Key Information: This is a forecasted opportunity; application details and funding amounts will be released in the official NOFO.